Page last updated: 2024-08-24

oseltamivir and Shock, Septic

oseltamivir has been researched along with Shock, Septic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Gao, J; Li, D; Xia, H; Xiu, M1
Ala-Kokko, T; Herwald, H; Kaukonen, KM; Lindbom, L; Linko, R; Pettilä, V; Ruokonen, E1
Chuang, YC; Ku, YH; Yu, WL1
Bello, S; de Pablo, F; Fandos, S; Figueredo, AL; Minchole, E; Omeñaca, M; Panadero, C; Royo, L; Vengoechea, JJ1
Boura, P; Mouloudi, E; Sarantopoulos, A; Tselios, K; Tsioka, R1
Bonastre, J; Guerrero, JE; Martín-Loeches, I; Pozo, JC; Rodríguez, A; Suberviola, B; Torres, A1

Other Studies

6 other study(ies) available for oseltamivir and Shock, Septic

ArticleYear
Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in a Chinese adult: A case report.
    Medicine, 2020, Jun-26, Volume: 99, Issue:26

    Topics: Aged; Anti-Bacterial Agents; Cough; Healthcare-Associated Pneumonia; Humans; Hypokinesia; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Mezlocillin; Oseltamivir; Shock, Septic; Staphylococcal Infections

2020
Heparin-binding protein (HBP) in critically ill patients with influenza A(H1N1) infection.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:12

    Topics: Adult; Antimicrobial Cationic Peptides; Antiviral Agents; Blood Proteins; Carrier Proteins; Critical Illness; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Oseltamivir; Polymerase Chain Reaction; Prospective Studies; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Shock, Septic

2013
Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2017, Volume: 116, Issue:5

    Topics: Aged; Antiviral Agents; Bronchoalveolar Lavage Fluid; Disease Management; Disease Progression; Fatal Outcome; Hemopneumothorax; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Lung; Male; Nasopharynx; Oseltamivir; Radiography; Shock, Septic; Thoracentesis

2017
Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
    PloS one, 2016, Volume: 11, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pneumonia; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Seasons; Shock, Septic; Treatment Outcome; Young Adult

2016
Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report.
    BMC infectious diseases, 2011, Dec-29, Volume: 11

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lupus Erythematosus, Systemic; Middle Aged; Oseltamivir; Radiography, Thoracic; Shock, Septic; Steroids; Tomography, X-Ray Computed; Vasoconstrictor Agents

2011
[Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010-2011 winter seasonal outbreak of influenza A (H1N1) in Spain].
    Medicina intensiva, 2012, Volume: 36, Issue:3

    Topics: Acute Kidney Injury; Adult; Antiviral Agents; Disease Outbreaks; Extracorporeal Membrane Oxygenation; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Length of Stay; Male; Multiple Organ Failure; Oseltamivir; Pneumonia, Viral; Prospective Studies; Renal Replacement Therapy; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Seasons; Shock, Septic; Spain

2012